Association of antihypertensive monotherapy with serum sodium and potassium levels in Chinese patients (American Journal of Hypertension (2009) (243-249) DOI: 10.1038/ajh.2008.359);Association of antihypertensive monotherapy with serum sodium and potassium levels in Chinese patients

American Journal of Hypertension

Volumn 22, Issue 3, 2009, Pages 243-249

  Jiang, Johnny Y ^a   Wong, Martin C S ^a   Ali, Mohammed K ^a   Griffiths, Sian M ^a   Mercer, Stewart W ^a,b  

^a Prince of Wales Hospital   (Hong Kong)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; POTASSIUM; SODIUM; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CHINESE; FEMALE; HONG KONG; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPONATREMIA; MAJOR CLINICAL STUDY; MALE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM BLOOD LEVEL; TREATMENT RESPONSE;

EID: 60549107012     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2009.40     Document Type: Erratum

References (21)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252.
2. National Collaborating Centre for Chronic Conditions. Hypertension: Management in Adults in Primary Care: Pharmacological Update. Royal College of Physicians: London, 2006.
3. Greenberg A. Diuretic complications. Am J Med Sci 2000; 319:10-24.
4. Wilcox CS. Metabolic and adverse effects of diuretics. Semin Nephrol 1999; 19:557-568.
5. Chan TYK, Critchley JAJH. Reporting of adverse drug reactions in relation to general medical admissions to a teaching hospital in Hong Kong. Pharmacoepidemiol Drug Saf 1994; 3:85-89.
6. Wong MCS, Chung RY. The prescription pattern of first-line anti-hypertensives among family medicine trainees in Hong Kong Part 1: in the absence of concomitant cardiovascular risk factors. Hong Kong Practitioner 2004; 26:420-429.
7. Chow KM, Szeto CC, Wong TY-H, Leung CB, Li PK-T. Risk factors for thiazide-induced hyponatraemia. QJM 2003; 96:911-917.
8. Brown MJ. Hypertension and ethnic group. BMJ 2006; 332:833-836.
9. Cheung NT, Health informatics, Hospital Authority, Hong Kong. Realizing the benefits of eHealth in Hong Kong. 〈http://www.ehealth.org.hk/Speaker/ Dr%20Ngai%20Tseung%20CHEUNG.pdf〉 (2006). Accessed 19 September 2007.
10. Wong MCS, Jiang Y, Tang JL, Lam A, Fung H, Mercer SW. Health services research in the public healthcare system in Hong Kong: an analysis of over 1 million antihypertensive prescriptions between 2004-2007 as an example of the potential and pitfalls of using routinely collected electronic patient data. BMC Health Serv Res 2008; 8:138.
11. Population by-census, 2006, Hong Kong Special Administrative Region, China. 〈http://www.bycensus2006.gov.hk/data/data2/index.htm〉 (2006). Accessed 09 October 2007.
12. Halpern MT, Khan ZM, Schmier JK, Burnier M, Caro JJ, Cramer J, Daley WL, Gurwitz J, Hollenberg NK. Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension 2006; 47:1039-1048.
13. Cockcroft DW, Gault HM. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
14. Clayton JA, Rodgers S, Blakey J, Avery A, Hall IP. Thiazide diuretic prescription and electrolyte abnormalities in primary care. Br J Clin Pharmacol 2005; 61:87-95.
15. Pikilidou MI, Lasaridis AN, Sarafidis PA, Tziolas IM, Zebekakis PE, Dombros NV, Giannoulis E. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment. Clin Exp Hypertens 2007; 29:563-573.
16. Bissram M, Scott FD, Liu L, Rosner MH. Risk factors for symptomatic hyponatraemia: the role of pre-existing asymptomatic hyponatraemia. Intern Med J 2007; 37:149-155.
17. Chang S, Chan WH, Kong Y, Chan GMC, Raymond K, Lee A, Lee SC, Critchley JA, Chan JC. Use of indapamide in hospital and community clinics and its effect on plasma potassium in Chinese patients. J Clin Pharm Ther 1998; 23:295-302.
18. Sharabi Y, Illan R, Kamari Y, Cohen H, Nadler M, Messerli FH, Grossman E. Diuretic induced hyponatremia in elderly hypertensive women. J Hum Hypertens 2002; 16:631-635.
19. Freed MI, Rastegar A, Bia MJ. Effects of calcium channel blockers on potassium homeostasis. Yale J Biol Med 1991; 64:177-186.
20. Wong MCS, Jiang JY, Ali MK, Fung H, Griffiths S, Mercer SW. Antihypertensive drug class and dyslipidemia: risk association among Chinese patients with uncomplicated hypertension. J Hum Hypertens 2008; 22: 648-651.
21. Wong MCS, Jiang JY, Fung H, Griffiths S, Mercer SW. Antihypertensive drug class and impaired fasting glucose: a risk association study among Chinese patients with uncomplicated hypertension. BMC Clin Pharmacol 2008; 8:6.